Protective effects of resveratrol on salivary gland damage induced by total body irradiation in rats

Laryngoscope

Volumn 122, Issue 12, 2012, Pages 2743-2748

  Şimşek, Gökçe ^a   Gürocak, Şimay ^b   Karadaǧ, Neşe ^b   Karabulut, Aysun Bay ^b   Demirtaş, Erol ^a   Karataş, Erkan ^b   Pepele, Eda ^b  

^a MINISTRY OF HEALTH   (Turkey)

^b INONU UNIVERSITY   (Turkey)

Author keywords

oxidative stress; Radiation; resveratrol; salivary gland

Indexed keywords

GLUTATHIONE; MALONALDEHYDE; NITRIC OXIDE; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HISTOLOGY; NONHUMAN; PAROTID GLAND; PRIORITY JOURNAL; RADIATION INJURY; RAT; SALIVARY GLAND DISEASE; SUBMANDIBULAR GLAND; WHOLE BODY RADIATION;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE; MALONDIALDEHYDE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SALIVARY GLAND DISEASES; SALIVARY GLANDS; STILBENES; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 84871273461     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.23609     Document Type: Article

References (29)

1. Mizoe JE, Hasegawa A, Jingu K, et al. Results of carbon ion radiotherapy for head and neck cancer. Radiother Oncol 2012; 103: 32-37.
2. Nunez MI, McMillan TJ, Valenzuela MT, Ruiz de Almodovar JM, Pedraza V,. Relationship between DNA damage, rejoining and cell killing by radiation in mammalian cells. Radiother Oncol 1996; 39: 155-165.
3. Di Pietro C, Piro S, Tabbi G, et al. Cellular and molecular effects of protons: apoptosis induction and potential implications for cancer therapy. Apoptosis 2006; 11: 57-66.
4. Kumar S, Ram S, Navazesh M,. Salivary gland and associated complications in head and neck cancer therapy. J Calif Dent Assoc 2011; 39: 639-647.
5. Davies AN, Broadley K, Beighton D,. Xerostomia in patients with advanced cancer. J Pain Symptom Manage 2001; 22: 820-825.
6. Soleas GJ, Diamandis EP, Goldberg DM,. Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 1997; 11: 287-313.
7. Baur JA, Sinclair DA,. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006; 5: 493-506.
8. Bradamante S, Barenghi L, Villa A,. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 2004; 22: 169-188.
9. Ara C, Kirimlioglu H, Karabulut AB, et al. Protective effect of resveratrol against oxidative stress in cholestasis. J Surg Res 2005; 127: 112-117.
10. Zhang F, Liu J, Shi JS,. Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur J Pharmacol 2010; 25; 636:1-637.
11. Nagler RM, Laufer D,. Protection against irradiation-induced damage to salivary glands by adrenergic agonist administration. Int J Radiat Oncol Biol Phys 1998; 15; 40: 477-481.
12. Coppes RP, Zeilstra LJ, Kampinga HH, Konings AW,. Early to late sparing of radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists. Br J Cancer 2001; 85: 1055-1063.
13. Nagler RM, Baum BJ, Fox PC,. Acute effects of X irradiation on the function of rat salivary glands. Radiat Res 1993; 136: 42-47.
14. Esterbauer H, Cheeseman KH,. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990: 186; 407-421.
15. Cortas NK, Wakid NW,. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36: 1440-1443.
16. Pagia DE, Valentine WN,. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967: 70; 158-170.
17. Lee HJ, Lee YJ, Kwon HC, et al. Radioprotective effect of heat shock protein 25 on submandibular glands of rats. Am J Pathol 2006; 169: 1601-1611.
18. Umegaki K, Aoki S, Esashi T,. Whole body irradiation to mice decrease ascorbic acid concentrations in bone marrow: comparison with vitamin E. Free Radic Biol Med 1995; 19: 493-497.
19. Umegaki K, Ichikawa T,. Decrease in vitamin E levels in the bone marrow of mice receiving whole-body X-ray irradiation. Free Radic Biol Med 1994; 17: 439-444.
20. Liem IH, Olmos RAV, Balm AJM, Keus RB, van Tinteren H, Takes RP,. Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours. Eur J Nucl Med 1996; 23: 1485-1490.
21. Taylor SE, Miller EG,. Preemptive pharmacologic intervention in radiation- induced salivary dysfunction. Proc Soc Exp Biol Medical 1999; 221: 14-26.
22. Nagler RM,. The enigmatic mechanism of irradiation-induced damage to the major salivary glands. Oral Dis 2002; 8: 141-146.
23. Pontual MLA, Tuji FM, Barros SP, Boscolo FN, Novaes PD, de Almeida SM,. Ultrastructural evaluation of the radioprotective effect of sodium selenite on submandibular glands in rats. J Appl Oral Sci 2007; 15: 162-168.
24. Medina VA, Prestifilippo JP, Croci M, et al. Histamine prevents functional and morphological alterations of submandibular glands induced by ionising radiation. Int J Radiat Biol 2011; 87: 284-292.
25. Cotrim AP, Hyodo F, Matsumoto K, et al. Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging. Clin Cancer Res 2007; 13: 4928-4933.
26. Rubiolo JA, Mithieux G, Vega FV,. Resveratrol protects primary rat hepatocytes against oxidative stress damage: activation of the Nrf2 transcription factor and augmented activities of antioxidant enzymes. Eur J Pharmacol 2008; 591: 66-72.
27. Li Y, Cao Z, Zhu H,. Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol Res 2006; 53: 6-15.
28. Di Franco R, Calvanese M, Murino P, et al. Skin toxicity from external beam radiation therapy in breast cancer patients: protective effects of resveratrol, lycopene, vitamin C and anthocianin (Ixor®). Radiat Oncol 2012; 30: 7-12.
29. Nakayama A, Alladin KP, Igbokwe O, White JD,. Systematic review: generating evidence-based guidelines on the concurrent use of dietary antioxidants and chemotherapy or radiotherapy. Cancer Invest 2011; 29: 655-667.